The Aging Brain Matrix: Cross-Species Evidence Linking FREM3 to Brain and Cognitive Aging
This study provides the first cross-species causal evidence that the age-dependent gene FREM3 is essential for maintaining brain volume and cognitive function, demonstrating that its loss in mice leads to accelerated brain atrophy and cognitive decline, while reduced genetically regulated expression in humans similarly correlates with smaller brain surface area and poorer cognitive performance.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
As we grow older, our brains naturally change. Some of these changes are subtle, like a slight slowing of memory, while others can be more profound, leading to conditions like Alzheimer's disease. Scientists have long known that the brain is not just a collection of neurons firing signals; it is a complex structure held together by a scaffolding of proteins and sugars known as the extracellular matrix. Think of this matrix as the mortar between the bricks of a building, providing essential support and stability. When this scaffolding weakens or changes over time, the structure of the brain can begin to shrink, and our ability to think and remember can decline. For years, researchers have searched for specific genes that control this scaffolding and determine how well our brains hold up against the passage of time. One such gene, called FREM3, has recently emerged as a critical player. It is highly active in the parts of the brain responsible for long-distance communication between different regions, and studies have shown that its levels drop significantly as people age. However, until now, no one knew for certain if this drop in levels was actually causing the brain to age faster, or if it was simply a side effect of other changes happening in the body.
A team of researchers set out to solve this mystery by looking at the same gene in two very different species: mice and humans. They wanted to see if lowering the levels of this gene would directly lead to a shrinking brain and worse thinking skills. To do this, they first created a special type of mouse where the gene was turned off specifically in the brain's excitatory neurons, the cells responsible for sending signals. They then compared these mice to normal mice at two different stages of life: young adulthood and middle age. The results were striking. The mice with the turned-off gene showed a dramatic loss of brain volume as they aged, shrinking significantly more than their normal counterparts. This shrinkage was not random; it happened in specific areas of the brain that are crucial for thinking and movement, including the frontal regions and the cerebellum. In contrast, the normal mice did not show this kind of age-related shrinking. Furthermore, when the researchers tested the mice on a simple memory task involving a Y-shaped maze, the mice with the turned-off gene performed poorly, regardless of whether they were young or middle-aged. This suggested that the gene is essential for maintaining the brain's physical structure and the memory functions that depend on it.
To see if these findings applied to people, the researchers turned to a massive database of human health and genetic information known as the UK Biobank. They could not turn off a gene in humans, so instead, they looked at the natural genetic differences between people that cause some individuals to have lower levels of the FREM3 gene than others. They found that people with lower natural levels of this gene had smaller total surface areas in their brains, particularly in the back parts of the brain involved in vision and the areas that help us connect our thoughts. Just as in the mice, this reduction in brain size was linked to lower performance on various cognitive tests. The study revealed that the gene's effect on thinking skills was largely indirect: having lower levels of the gene led to a smaller brain structure, and that smaller structure, in turn, made it harder to perform well on mental tasks. This connection held true across a wide range of ages, from the mid-forties to the eighties.
The researchers were careful to note that their human findings were based on natural genetic variations, which means they could not prove that the gene causes the changes in the same direct way they did in the mice. However, the fact that the same gene showed such similar effects in both species provides strong evidence that it plays a fundamental role in keeping the brain healthy as we age. The study suggests that the FREM3 gene acts as a guardian of the brain's structural integrity. When its levels are high, the brain maintains its size and shape; when levels drop, the brain begins to lose volume, and our cognitive abilities suffer. This discovery offers a new target for scientists who hope to develop treatments to slow down brain aging. By understanding how this gene supports the brain's scaffolding, future therapies might be able to boost its levels or protect it from decline, potentially helping to preserve memory and thinking skills in older adults. The work bridges the gap between animal experiments and human biology, showing that the rules governing brain aging are deeply conserved across species and that a single gene can have a profound impact on how our minds age.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.